The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.
Renaud Chollet, Jacqueline Chevalier, André Bryskier, Jean-Marie Pagès
Index: Antimicrob. Agents Chemother. 48(9) , 3621-4, (2004)
Full Text: HTML
Abstract
The role of the AcrAB-TolC pump in macrolide and ketolide susceptibility in Escherichia coli and Enterobacter aerogenes was studied. Efflux pump inhibitor restored erythromycin, clarithromycin, and telithromycin susceptibilities to multidrug-resistant isolates. No modification of telithromycin accumulation was detected in E. aerogenes acrAB or tolC derivatives compared to that in the parental strain. Two independent efflux pumps, inhibited by phenylalanine arginine beta-naphthylamide, expel macrolides and telithromycin in E. aerogenes.
Related Compounds
Related Articles:
A novel mammalian high-molecular-weight aminopeptidase.
1997-08-01
[Arch. Biochem. Biophys. 344(1) , 228-34, (1997)]
Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.
2013-11-19
[Biochemistry 52(46) , 8342-51, (2013)]
1993-02-01
[J. Clin. Microbiol. 31(2) , 279-82, (1993)]
[Cell Mol. Biol. 36(2) , 175-9, (1990)]
2011-03-15
[Int. J. Food Microbiol. 146(1) , 52-6, (2011)]